A pharmacovigilance study on Memantine: signal detection of Rhabdomyolysis and death

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.

Bibliographic Details
Main Author: Bakar, Osama Bin Abu
Other Authors: Yasmin, Hasina
Format: Thesis
Language:English
Published: Brac University 2024
Subjects:
Online Access:http://hdl.handle.net/10361/23186
id 10361-23186
record_format dspace
spelling 10361-231862024-06-06T21:02:40Z A pharmacovigilance study on Memantine: signal detection of Rhabdomyolysis and death Bakar, Osama Bin Abu Yasmin, Hasina School of Pharmacy, Brac University Alzheimer’s disease Neurological disorder Dementia FAERS database FDA adverse event reporting system Rhabdomyolysis Alzheimer's disease--Therapy Nervous System Diseases This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023. Cataloged from the PDF version of thesis. Includes bibliographical references (pages 42-48). Alzheimer's Disease (AD) is a complex and common neurological disorder and dementia's leading cause. Memantine works to treat moderate to severe AD. This study focused on Food and Drug Administration Adverse Event Reporting System (FAERS) data with the purpose to determine its effect on adverse events of Death and Rhabdomyolysis based on two comparators; the whole database and drug class. To conduct this disproportionality analysis, we have incorporated ROR and 95% CI values. We figured out that memantine possesses a higher mortality benefits ratio than other drugs enlisting both the comparators; whole database and drug class with a value of (ROR = 0.68; CI 95% = 0.46–1.00; P = 0.0483) and (ROR = 0.19; CI 95% = 0.13–0.28; P <0.0001) respectively. In addition, in the cases of rhabdomyolysis, we also find out that memantine has a lower profile assigning both comparators 8.10 (4.48 to 14.67; p < 0.0001); whole database and 2.25 (1.11 to 4.54; P = 0.0241); drug class. Osama Bin Abu Bakar B. Pharmacy 2024-06-06T04:51:48Z 2024-06-06T04:51:48Z ©2023 2023-02 Thesis ID: 19146094 http://hdl.handle.net/10361/23186 en Brac University theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission. 61 pages application/pdf Brac University
institution Brac University
collection Institutional Repository
language English
topic Alzheimer’s disease
Neurological disorder
Dementia
FAERS database
FDA adverse event reporting system
Rhabdomyolysis
Alzheimer's disease--Therapy
Nervous System Diseases
spellingShingle Alzheimer’s disease
Neurological disorder
Dementia
FAERS database
FDA adverse event reporting system
Rhabdomyolysis
Alzheimer's disease--Therapy
Nervous System Diseases
Bakar, Osama Bin Abu
A pharmacovigilance study on Memantine: signal detection of Rhabdomyolysis and death
description This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.
author2 Yasmin, Hasina
author_facet Yasmin, Hasina
Bakar, Osama Bin Abu
format Thesis
author Bakar, Osama Bin Abu
author_sort Bakar, Osama Bin Abu
title A pharmacovigilance study on Memantine: signal detection of Rhabdomyolysis and death
title_short A pharmacovigilance study on Memantine: signal detection of Rhabdomyolysis and death
title_full A pharmacovigilance study on Memantine: signal detection of Rhabdomyolysis and death
title_fullStr A pharmacovigilance study on Memantine: signal detection of Rhabdomyolysis and death
title_full_unstemmed A pharmacovigilance study on Memantine: signal detection of Rhabdomyolysis and death
title_sort pharmacovigilance study on memantine: signal detection of rhabdomyolysis and death
publisher Brac University
publishDate 2024
url http://hdl.handle.net/10361/23186
work_keys_str_mv AT bakarosamabinabu apharmacovigilancestudyonmemantinesignaldetectionofrhabdomyolysisanddeath
AT bakarosamabinabu pharmacovigilancestudyonmemantinesignaldetectionofrhabdomyolysisanddeath
_version_ 1814308094943952896